Clinical Trials Browser

Has results × Pancreatic Neoplasms × CTLA-4 Antigen × Clear all

NCT01473940 2020-03-06

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 1 Completed

21 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms